The trademark ABSIVTA was filed by Genzyme Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on July 15, 2020, and received one opposition filed on September 20, 2020 by CHIESI FARMACEUTICI S.P.A. on Likelihood of confusion. the opponent was represented by GIAMBROCONO & C. S.P.A. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 20, 2020
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).